| abstract |
This invention provides 5-HT 1F agonists of Formula I: ##STR1## where A-B, X, and R are as defined in the specification. The invention also encompasses pharmaceutical formulations employing compounds of Formula I as well as methods of treating conditions associated with 5-HT 1F activation employing these compounds or compositions. The invention also provides intermediates useful for the preparation of the compounds of Formula I. |